PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
PROVECTUS BIOPHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026
- Market cap
- $20.55M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 11, 2002 | 1-for-300 reverse | Earlier per-share figures multiplied by 300 |
| Jun 28, 2000 | 1-for-5000 reverse | Earlier per-share figures multiplied by 5000 |